Barclays’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.63M Buy
27,216
+6,501
+31% +$389K ﹤0.01% 2366
2025
Q1
$1.09M Sell
20,715
-4,401
-18% -$231K ﹤0.01% 2399
2024
Q4
$1.38M Buy
25,116
+1,342
+6% +$73.8K ﹤0.01% 2441
2024
Q3
$1.2M Buy
23,774
+12,657
+114% +$637K ﹤0.01% 2518
2024
Q2
$488K Sell
11,117
-3,635
-25% -$160K ﹤0.01% 2551
2024
Q1
$649K Sell
14,752
-4,766
-24% -$210K ﹤0.01% 2687
2023
Q4
$926K Buy
19,518
+8,862
+83% +$420K ﹤0.01% 2652
2023
Q3
$472K Buy
10,656
+3,203
+43% +$142K ﹤0.01% 2584
2023
Q2
$356K Sell
7,453
-2,049
-22% -$97.9K ﹤0.01% 2795
2023
Q1
$374K Buy
9,502
+1,856
+24% +$73.1K ﹤0.01% 2825
2022
Q4
$216K Buy
7,646
+2,587
+51% +$73.1K ﹤0.01% 3051
2022
Q3
$152K Sell
5,059
-56
-1% -$1.68K ﹤0.01% 3230
2022
Q2
$173K Sell
5,115
-13,273
-72% -$449K ﹤0.01% 3218
2022
Q1
$825K Buy
18,388
+4,309
+31% +$193K ﹤0.01% 2456
2021
Q4
$650K Buy
14,079
+5,104
+57% +$236K ﹤0.01% 2411
2021
Q3
$301K Buy
8,975
+1,791
+25% +$60.1K ﹤0.01% 2806
2021
Q2
$212K Sell
7,184
-4,117
-36% -$121K ﹤0.01% 2861
2021
Q1
$290K Buy
11,301
+1,641
+17% +$42.1K ﹤0.01% 2960
2020
Q4
$220K Sell
9,660
-509
-5% -$11.6K ﹤0.01% 2661
2020
Q3
$216K Sell
10,169
-2,753
-21% -$58.5K ﹤0.01% 2697
2020
Q2
$299K Buy
12,922
+8,553
+196% +$198K ﹤0.01% 2605
2020
Q1
$93K Sell
4,369
-2,993
-41% -$63.7K ﹤0.01% 2859
2019
Q4
$171K Buy
7,362
+2,010
+38% +$46.7K ﹤0.01% 3248
2019
Q3
$113K Buy
5,352
+2,509
+88% +$53K ﹤0.01% 3340
2019
Q2
$58K Sell
2,843
-53
-2% -$1.08K ﹤0.01% 3793
2019
Q1
$82K Buy
2,896
+837
+41% +$23.7K ﹤0.01% 3426
2018
Q4
$50K Buy
2,059
+721
+54% +$17.5K ﹤0.01% 3175
2018
Q3
$50K Buy
1,338
+237
+22% +$8.86K ﹤0.01% 3740
2018
Q2
$24K Buy
1,101
+1,087
+7,764% +$23.7K ﹤0.01% 3555
2018
Q1
$0 Buy
+14
New ﹤0.01% 4279
2017
Q2
Sell
-1,319
Closed -$12K 3963
2017
Q1
$12K Buy
1,319
+1,152
+690% +$10.5K ﹤0.01% 3488
2016
Q4
$2K Buy
167
+130
+351% +$1.56K ﹤0.01% 3604
2016
Q3
$1K Buy
+37
New +$1K ﹤0.01% 3749
2016
Q1
Sell
-19,177
Closed -$537K 3551
2015
Q4
$537K Buy
19,177
+13,862
+261% +$388K ﹤0.01% 1652
2015
Q3
$127K Buy
5,315
+5,261
+9,743% +$126K ﹤0.01% 2289
2015
Q2
$1K Buy
+54
New +$1K ﹤0.01% 4008